Select for export Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25235 PubMed 35747039 Copy citation Copy BibTeX Unknown journal 2022-05-22 Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C Europe PMC Published psilocybin AnxietyPTSDEnd-of-Life Distress Other More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.841648 PubMed 35355714 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-08 McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S Europe PMC Published psilocybin Mystical ExperienceHealthy Volunteers Qualitative Study More
Select for export Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06020-5 PubMed 35234983 Copy citation Copy BibTeX Psychopharmacology 2022-03-01 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N Europe PMC Published psilocybinpsilocin DepressionReceptor Pharmacology Other More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06066-z PubMed 35076721 Copy citation Copy BibTeX Psychopharmacology 2022-01-24 Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y Europe PMC Published psilocybin Clinical TrialHealthy Volunteers Clinical Trial More
Select for export Analysis of recreational psychedelic substance use experiences classified by substance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06062-3 PubMed 35031816 Copy citation Copy BibTeX Psychopharmacology 2022-01-14 Hase A, Erdmann M, Limbach V, Hasler G. Europe PMC Published psilocybin AddictionBiomarkersEmotional Processing Clinical Trial More
Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/jpssuppl.96.0_4-b-s43-2 Copy citation Copy BibTeX Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021-12-31 Daisuke Ibi OpenAlex Published psilocybinpsilocin DepressionPharmacologyMechanism of Action Animal Study More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin: a psychedelic alternative to antidepressants? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.169269 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Select for export Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/jpssuppl.95.0_3-s35-1 Copy citation Copy BibTeX Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021-12-31 Daisuke Ibi OpenAlex Published psilocybinpsilocin DepressionNeuroplasticityPharmacology Animal Study More
Select for export Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058933 PubMed 35090364 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-12-31 Jones GM, Nock MK. Europe PMC Published psilocybin AddictionPersonality ChangeObservational Study Observational Study More
Select for export Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.831092 PubMed 35370864 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Raison CL, Jain R, Penn AD, Cole SP, Jain S PubMed Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
